Chimerix Inc (NASDAQ: NASDAQ:CMRX) stock has reached a new 52-week high, touching the $4.3 mark, signaling a significant ...
India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果